- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01945515
Robotic-assisted Gait Training Combined With Transcranial Direct Current Stimulation to Maximize Gait Recovery After Stroke
December 18, 2016 updated by: Byung-Mo Oh, Seoul National University Hospital
Robotic-assisted Gait Training Combined With Transcranial Direct Current Stimulation to Maximize Gait Recovery After Stroke: A Double-blind, Randomized, Controlled Trial
- Study objective To evaluate the effect of robotic-assisted gait training combined with transcranial direct current stimulation (tDCS) as compared to that of robotic-assisted gait training on gait function of chronic stroke patients
- Subjects chronic stroke patients with gait impairment
Methods
- Group 1: Robotic-assisted gait training with anodal tDCS (45 min)
- Group 2: Robotic-assisted gait training with sham tDCS (45 min)
- Duration of treatment: 2 weeks, 5 times a week
- Evaluation: Baseline, 1 day after the treatment, 4 weeks after the treatment
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Stroke patients who diagnosed by computed tomography or magnetic resonance imaging
- Hemiplegic patients due to unilateral lesion
- Patients in chronic stage after 6 months from stroke onset
- Patients with gait impairment (FAC <= 4)
- Adult (Age >= 18)
Exclusion Criteria:
- Unstable vital sign
- History of seizure or cranial operation
- unable to walk before stroke
- bilateral hemispheric lesions
- metalic implant (cardiac pacemaker, artificial cochlear, etc.)
- severe cognitive deficit, MMSE < 10
- severe aphasic patient who cannot communicate at all
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Robot + anodal tDCS
Robotic-assisted gait training for 45 min after anodal tDCS on impaired motor cortex for 20 min
|
tDCS will be applied on the primary motor cortex of the lower limb in the impared hemisphere before robotic-assisted gait training.
Anodal tDCS will be applied with an intensity of 2mA for 20 min.
Sham tDCS will be applied with an intensity of 2mA just for 1 min, after which the current will be slowly tapered down to 0 over a several seconds.
Other Names:
Robotic-assisted gait training with an exoskeletal type robot which simulates normal walking on a treadmill for patients with gait impairments
Other Names:
|
|
Sham Comparator: Robot + sham tDCS
Robotic-assisted gait training for 45 min after sham tDCS on impaired motor cortex for 20 min
|
tDCS will be applied on the primary motor cortex of the lower limb in the impared hemisphere before robotic-assisted gait training.
Anodal tDCS will be applied with an intensity of 2mA for 20 min.
Sham tDCS will be applied with an intensity of 2mA just for 1 min, after which the current will be slowly tapered down to 0 over a several seconds.
Other Names:
Robotic-assisted gait training with an exoskeletal type robot which simulates normal walking on a treadmill for patients with gait impairments
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Ambulatory Category (FAC)
Time Frame: Baseline
|
Assesses functional ambulation in patients undergoing physical therapy
|
Baseline
|
|
Functional Ambulatory Category (FAC)
Time Frame: 1 day after treatment
|
Assesses functional ambulation in patients undergoing physical therapy
|
1 day after treatment
|
|
Functional Ambulatory Category (FAC)
Time Frame: 4 weeks after treatment
|
Assesses functional ambulation in patients undergoing physical therapy
|
4 weeks after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
10-meter walk test
Time Frame: Baseline
|
Time for walking 10 meters
|
Baseline
|
|
10-meter walk test
Time Frame: 1 day after treatment
|
Time for walking 10 meters
|
1 day after treatment
|
|
10-meter walk test
Time Frame: 4 weeks after treatment
|
Time for walking 10 meters
|
4 weeks after treatment
|
|
6-min walk test
Time Frame: Baseline
|
Walking distance for 6 min
|
Baseline
|
|
6-min walk test
Time Frame: 1 day after treatment
|
Walking distance for 6 min
|
1 day after treatment
|
|
6-min walk test
Time Frame: 4 weeks after treatment
|
Walking distance for 6 min
|
4 weeks after treatment
|
|
Modified Rankin's Scale
Time Frame: Baseline
|
Baseline
|
|
|
Modified Rankin's Scale
Time Frame: 1 day after treatment
|
1 day after treatment
|
|
|
Modified Rankin's Scale
Time Frame: 4 weeks after treatment
|
4 weeks after treatment
|
|
|
Fugl-Meyer assessment scale for lower extremity
Time Frame: Baseline
|
Assess the function of lower extremity in stroke patients
|
Baseline
|
|
Fugl-Meyer assessment scale for lower extremity
Time Frame: 1 day after treatment
|
Assess the function of lower extremity in stroke patients
|
1 day after treatment
|
|
Fugl-Meyer assessment scale for lower extremity
Time Frame: 4 weeks after treatment
|
Assess the function of lower extremity in stroke patients
|
4 weeks after treatment
|
|
Motor evoked potential
Time Frame: Baseline
|
Assess motor pathway from brain cortex to the muscle by transcranial magnetic stimulation
|
Baseline
|
|
Motor evoked potential
Time Frame: 1 day after treatment
|
Assess motor pathway from brain cortex to the muscle by transcranial magnetic stimulation
|
1 day after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Byung-Mo Oh, MD, PhD, Seoul National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
September 15, 2013
First Submitted That Met QC Criteria
September 17, 2013
First Posted (Estimate)
September 18, 2013
Study Record Updates
Last Update Posted (Estimate)
December 20, 2016
Last Update Submitted That Met QC Criteria
December 18, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Robot-tDCS-2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
Clinical Trials on tDCS
-
Northeastern UniversityMassachusetts General Hospital; National Institute on Aging (NIA)Unknown
-
Hôpital le VinatierCompletedSchizophrenia | Auditory HallucinationsFrance, Tunisia
-
Universidad de AlmeriaSecretaría General de Universidades, Investigación y Tecnología, Junta de...Enrolling by invitationSubstance-Related DisordersSpain
-
Thorsten RudroffTerminatedMultiple Sclerosis | Neuropathic PainUnited States
-
Nachum Soroker, MDUnknown
-
University of MichiganNational Institute of Mental Health (NIMH)Completed
-
New York UniversityRecruiting
-
Tianjin Eye HospitalRecruiting
-
Universidade Federal de PernambucoCompleted
-
Xuanwu Hospital, BeijingBeijing Tiantan Hospital; Second Affiliated Hospital of Tsinghua UniversityNot yet recruitingNeuropathic Pain